# Shanghai Jiao Tong University School of Medicine: Phase 4 study in Hypertension (456 participants)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Shanghai Jiao Tong University School of Medicine |
| Sponsor type | Academic and hospital |
| Study | Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney Damage |
| NCT ID | NCT07876544 |
| Phase | Phase 4 |
| Status | recruiting |
| Conditions | Hypertension |
| Intervention types | drug |
| Target enrollment | 456 |
| Site countries | China |
| Posted | 2026-10-15 |
| Planned start | 2026-09-22 |
| Event | Newly registered study |
| Event date | 2026-10-15 |

## Why this score
- 456 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07876544). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.